Cargando…

Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care

PURPOSE: To identify the associations between MetS and its components and chronic kidney disease (CKD) in a population with arterial hypertension (AH), or diabetes mellitus (DM) accompanied by the Primary Health Care (PHC). PATIENTS AND METHODS: A cross-sectional study with 788 individuals diagnosed...

Descripción completa

Detalles Bibliográficos
Autores principales: Comini, Luma de O, de Oliveira, Laura C, Borges, Luiza D, Dias, Heloísa H, Batistelli, Clara R S, da Silva, Luciana S, Moreira, Tiago R, da Silva, Rodrigo G, Cotta, Rosângela M M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956993/
https://www.ncbi.nlm.nih.gov/pubmed/32021353
http://dx.doi.org/10.2147/DMSO.S223929
_version_ 1783487241929097216
author Comini, Luma de O
de Oliveira, Laura C
Borges, Luiza D
Dias, Heloísa H
Batistelli, Clara R S
da Silva, Luciana S
Moreira, Tiago R
da Silva, Rodrigo G
Cotta, Rosângela M M
author_facet Comini, Luma de O
de Oliveira, Laura C
Borges, Luiza D
Dias, Heloísa H
Batistelli, Clara R S
da Silva, Luciana S
Moreira, Tiago R
da Silva, Rodrigo G
Cotta, Rosângela M M
author_sort Comini, Luma de O
collection PubMed
description PURPOSE: To identify the associations between MetS and its components and chronic kidney disease (CKD) in a population with arterial hypertension (AH), or diabetes mellitus (DM) accompanied by the Primary Health Care (PHC). PATIENTS AND METHODS: A cross-sectional study with 788 individuals diagnosed with AH and/or DM followed by PHC of Viçosa, Brazil. Anthropometric, biochemical and clinical measures were performed for the diagnosis of MetS and CKD. MetS was identified using the NCEP-ATPIII criteria. CKD was identified by estimating the glomerular filtration rate using the CKD-EPI equation. Logistic regression models were used to estimate the chances of CKD associated with MetS and its components and specific combinations of components. RESULTS: The prevalence of MetS reported in the population was 65.4%, that of hidden CKD was 15.4%. The prevalence of CKD among participants with MetS was 75.2%. The most prevalent component of MetS in the population was AH (96.7%). Elevated fasting blood glucose, central obesity, and reduced HDL-c were significantly associated with an increased chance of CKD (OR = 2.80, 95% CI 1.76–4.45, OR = 1.68, 95% CI, 05–2.71, OR = 1.61, CI 95% 1.03–2.50, respectively). For the multivariate adjustment, the participants with MetS were 2 times more likely to have CKD than those without MetS (OR = 2.07; 95% CI, 1.25–3.44). The combination of three components of MetS high blood pressure, abdominal obesity and elevated fasting blood glucose and the combination of four components of MetS high blood pressure, reduced HDL-c, high fasting blood glucose and abdominal obesity were associated with increased odds of CKD (OR = 2.67, CI 95% 1.70–4.20, OR = 2.50, CI 95% 1.55–4.02, respectively). CONCLUSION: MetS, as well as its individual or combined components were independently associated with CKD in the population with AH and/or DM accompanied by PHC.
format Online
Article
Text
id pubmed-6956993
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69569932020-02-04 Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care Comini, Luma de O de Oliveira, Laura C Borges, Luiza D Dias, Heloísa H Batistelli, Clara R S da Silva, Luciana S Moreira, Tiago R da Silva, Rodrigo G Cotta, Rosângela M M Diabetes Metab Syndr Obes Original Research PURPOSE: To identify the associations between MetS and its components and chronic kidney disease (CKD) in a population with arterial hypertension (AH), or diabetes mellitus (DM) accompanied by the Primary Health Care (PHC). PATIENTS AND METHODS: A cross-sectional study with 788 individuals diagnosed with AH and/or DM followed by PHC of Viçosa, Brazil. Anthropometric, biochemical and clinical measures were performed for the diagnosis of MetS and CKD. MetS was identified using the NCEP-ATPIII criteria. CKD was identified by estimating the glomerular filtration rate using the CKD-EPI equation. Logistic regression models were used to estimate the chances of CKD associated with MetS and its components and specific combinations of components. RESULTS: The prevalence of MetS reported in the population was 65.4%, that of hidden CKD was 15.4%. The prevalence of CKD among participants with MetS was 75.2%. The most prevalent component of MetS in the population was AH (96.7%). Elevated fasting blood glucose, central obesity, and reduced HDL-c were significantly associated with an increased chance of CKD (OR = 2.80, 95% CI 1.76–4.45, OR = 1.68, 95% CI, 05–2.71, OR = 1.61, CI 95% 1.03–2.50, respectively). For the multivariate adjustment, the participants with MetS were 2 times more likely to have CKD than those without MetS (OR = 2.07; 95% CI, 1.25–3.44). The combination of three components of MetS high blood pressure, abdominal obesity and elevated fasting blood glucose and the combination of four components of MetS high blood pressure, reduced HDL-c, high fasting blood glucose and abdominal obesity were associated with increased odds of CKD (OR = 2.67, CI 95% 1.70–4.20, OR = 2.50, CI 95% 1.55–4.02, respectively). CONCLUSION: MetS, as well as its individual or combined components were independently associated with CKD in the population with AH and/or DM accompanied by PHC. Dove 2020-01-09 /pmc/articles/PMC6956993/ /pubmed/32021353 http://dx.doi.org/10.2147/DMSO.S223929 Text en © 2020 Comini et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Comini, Luma de O
de Oliveira, Laura C
Borges, Luiza D
Dias, Heloísa H
Batistelli, Clara R S
da Silva, Luciana S
Moreira, Tiago R
da Silva, Rodrigo G
Cotta, Rosângela M M
Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title_full Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title_fullStr Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title_full_unstemmed Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title_short Individual and Combined Components of Metabolic Syndrome with Chronic Kidney Disease in Individuals with Hypertension and/or Diabetes Mellitus Accompanied by Primary Health Care
title_sort individual and combined components of metabolic syndrome with chronic kidney disease in individuals with hypertension and/or diabetes mellitus accompanied by primary health care
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956993/
https://www.ncbi.nlm.nih.gov/pubmed/32021353
http://dx.doi.org/10.2147/DMSO.S223929
work_keys_str_mv AT cominilumadeo individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT deoliveiralaurac individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT borgesluizad individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT diasheloisah individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT batistelliclarars individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT dasilvalucianas individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT moreiratiagor individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT dasilvarodrigog individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare
AT cottarosangelamm individualandcombinedcomponentsofmetabolicsyndromewithchronickidneydiseaseinindividualswithhypertensionandordiabetesmellitusaccompaniedbyprimaryhealthcare